Flavonoids as receptor tyrosine kinase inhibitors in lung cancer
Sareshma Sudhesh Dev(Monash University Malaysia), Rakesh Naidu(Monash University Malaysia), Reyhaneh Farghadani(Monash University Malaysia), Iekhsan Othman(Monash University Malaysia), Syafiq Asnawi Zainal Abidin(Monash University Malaysia)
Cited by 20
Related Papers
miRNA: A Promising Therapeutic Target in Cancer
|International Journal of Molecular Sciences|2022|335
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Current strategies in extending half-lives of therapeutic proteins
|Journal of Controlled Release|2019|285
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity
|Frontiers in Microbiology|2015|178